ATM/ATR

ATM/ATR 是丝氨酸/苏氨酸蛋白激酶 (PIKK) 磷脂酰肌醇 3 激酶样家族的成员,被广泛认为是有丝分裂 DNA 损伤反应 (DDR) 的核心参与者,分别对 DNA 双链断裂 (DSB) 和单链 DNA (ssDNA) 产生反应。通过电离辐射激活 ATM 会导致信号转导通路激活,从而诱导细胞周期在 G1/S、S 和 G2/M 停滞。ATR 是细胞周期停滞所必需的,以响应导致大面积病变的 DNA 损伤剂(例如紫外线辐射)。

激活后,ATM/ATR 磷酸化许多靶标以稳定停滞的复制叉、修复受损的 DNA 并抑制细胞周期进程,以确保细胞存活并保护基因组的完整性。ATM 和 ATR 是激活细胞周期检查点的核心参与者,并作为防止复制细胞中基因组不稳定性和肿瘤发生的主动屏障。

ATM/ATR, members of the phosphatidyl inositol 3-kinase-like family of serine/threonine protein kinases (PIKKs), are widely known as being central players in the mitotic DNA damage response (DDR), mounting responses to DNA double-strand breaks (DSBs) and single-stranded DNA (ssDNA) respectively. Activation of ATM by ionizing radiation results in the activation of signal transduction pathways that induce cell cycle arrest at G1/S, S and G2/M. ATR is required for cell cycle arrest in response to DNA-damaging agents such as ultraviolet radiation that cause bulky lesions.

Upon activation, ATM/ATR phosphorylate numerous targets to stabilize stalled replication forks, repair damaged DNA, and inhibit cell cycle progression to ensure survival of the cell and safeguard integrity of the genome. ATM and ATR are central players in activating cell cycle checkpoints and function as an active barrier against genome instability and tumorigenesis in replicating cells.

ATM/ATR亚型特异性产品:ATM/ATR Isoform Comparison
共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
LL-K12-18

LL-K12-18 是一种 CDK12 激酶抑制剂,也是一种双位点分子胶,它以 283.9 nM 的 IC50 值抑制人源 CDK12,并通过稳定 CDK12-DDB1 复合物经泛素-蛋白酶体系统选择性降解 cyclin K,同时下调 DNA 损伤应答基因、降低 RNA 聚合酶 II CTD Ser2 磷酸化水平并调节 ATM、RAD51、γ-H2AX 和剪切型 PARP 等标志物,从而有效诱导乳腺癌细胞凋亡 (apoptosis) 并抑制其增殖,且具有高度的靶向选择性,可用于三阴性乳腺癌的研究。

3081311-94-3
Modulator
98.42%
LL-K12-18

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础